The Alliance for Clinical Research Excellence and Safety (ACRES) has opened its first national affiliate, ACRES Japan, in Tokyo. Fumimaro Takaku, M.D., president of the Japanese Association of Medical Sciences, will act as president of the board of directors, and ACRES Japan will provide a model for the organization?s planned network of national affiliates.
The Alliance for Clinical Research Excellence and Safety (ACRES) has opened its first national affiliate, ACRES Japan, in Tokyo. Fumimaro Takaku, M.D., president of the Japanese Association of Medical Sciences, will act as president of the board of directors, and ACRES Japan will provide a model for the organization’s planned network of national affiliates.
ACRES Japan aims to develop high-quality clinical research both within Japan and worldwide by promoting education and training of investigators and study team members, supporting site accreditation, and developing an IT platform for effective information sharing.
"Clinical research must be conducted with high transparency; education and training of physician investigators for clinical research must be rigorous; a code of conduct for physicians collaborating with pharmaceutical companies for clinical search must be assured--addressing these concerns will lead to highest quality and efficiency of clinical research in Japan,” noted Takaku. “Through ACRES Japan, we are committed to finding effective solutions to these challenges.”
The executive officers are Kyoko Imamura, Ichiro Uchida, Kishio Ono, and Yasushi Suzuki. Planned activities range from advocating collaboration among like-minded organizations and individuals across Japan to participating in working groups of ACRES global initiatives and developing clinical research infrastructure in Japan. It will also create mechanisms to facilitate communication and collaboration between ACRES and local academic institutions, regulatory agencies, health systems, professional associations and patient organizations and to identify opportunities to further leverage ACRES-related Initiatives in Japan.
According to ACRES President Greg Koski, “This is a remarkable accomplishment by any measure. Organizations across the Japanese clinical research endeavor have shown extraordinary leadership, uniting to build a collaborative framework and expectation for excellence, one that will set very high standards and clear pathways for other nations seeking to achieve these goals. We look forward to our work together, not only with Japan, but with other countries worldwide.”
For the full press release, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.